New light microscope to pinpoint single proteins
Researchers have developed a new light microscope that is so powerful ituses a nanometre-scale resolution to spot individual proteins in a cell byusing a fluorescent labelling method.
Archives for August 14, 2006
Varian introduces HPLC columns for R&D applications
Varian makes available its new HPLC columns that are designed for use in the pharmaceutical industry, particularly in pre-clinical development, increasing productivity by enabling more products to be purified in less time.
Embrex helps Chinese vaccine producer not to lay an egg
Agricultural firm Embrex has installed its in ovo delivery system and egg remover at the production facility of Shenzhen Neptunus Interlong, believed to be the largest and most advanced human influenza vaccine manufacturing plant in China.
Manufacturing double whammy to cost Patheon millions
More problems at Patheon's Puerto Rican production facilities in the third quarter of 2006 are expected to reduce the contract manufacturer's earnings before interest, tax, depreciation and amortisation (EBITDA) by more than $9m (€7m) compared to last...
eClinical software proving popular
The use of eClinical software in clinical trials is gaining in popularity with pharmaceutical, biotechnology and contract research organizations (CROs), as seen by the recent financial results of two major industry providers.
Growing Astellas seeks Dendrite to manage samples
Astellas Pharma US has chosen to outsource its prescription drug sample accountability and compliance processes to Dendrite International.
Researchers identify potential new RA pathway
Biogen has revealed details of a potential new pathway in rheumatoid arthritis (RA) that could provide unique insights into the disease process and eventually a new approach to developing RA therapies.
Covance ignites wrath of animal activists
Covance, the world's largest provider of drug-development services, is bracing itself for the onslaught of protests by animal rights activists who are demonstrating against the building of a $100m (€78.6) laboratory in the US.
India geared up for unprecedented manufacturing growth
India's potential to further boost its already dominant role in global generics production, as well as an offshore location of choice for contract manufacturing, presents an opportunity worth an estimated $48bn (€38bn) in 2007, though regulatory...